🔎 Trials Near Me

Gara Jalqabaatti › Kansaar Onnee Triple-Negative › Washington › Seattle

Qorannoo klinikaalii Kansaar Onnee Triple-Negative Seattle, WA keessatti

Qorannoo 14 Kansaar Onnee Triple-Negative f Seattle fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Washington, Fred Hutchinson Cancer Center, Seattle
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04585750

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Fred Hutchinson Cancer Center, Seattle
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT04981119

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Namoota walitti qabaa jiraSadarkaa 3
  • Fred Hutchinson Cancer Center ( Site 0042), Seattle
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06841354

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Namoota walitti qabaa jiraSadarkaa 3
  • Fred Hutchinson Cancer Center ( Site 0069), Seattle
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06966700

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Swedish Medical Center, Seattle
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06618287

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • University of Washington Fred Hutchinson, Seattle
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT05983432

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Fred Hutchinson Cancer Center, Seattle
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06657222

SMP-3124LP in Adults With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Washington, Seattle
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT06526819

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Swedish Cancer Institute, Seattle
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT05579366

A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT07078604

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

Namoota walitti qabaa jiraSadarkaa 1
  • University Of Washington, Seattle
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT06562192

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Fred Hutchinson Cancer Center, Seattle
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT05377996

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Namoota walitti qabaa jiraSadarkaa 1/2
  • Fred Hutch Cancer Center, Seattle
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2025 · NCT06682793

A Study of NX-1607 in Adults With Advanced Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Fred Hutchinson Cancer Center, Seattle
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2025 · NCT05107674

Qorannoo Kansaar Onnee Triple-Negative magaalota biroo keessatti

Qorannoo biroo Seattle keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.